{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T13:30:51Z","timestamp":1786800651730,"version":"build-2736575974"},"reference-count":23,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"the Medical Science Research Project of Hebei","award":["NO. 20190354"],"award-info":[{"award-number":["NO. 20190354"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Med Res"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the predictive accuracy of the comparison of methods for thromboembolic risk assessment with clinical perceptions and awareness in real-life patients with cancer-associated thrombosis (COMPASS-CAT) risk model against the established Khorana score for predicting in-hospital venous thromboembolism in patients with solid tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study analyzed 482 inpatients with breast, lung, colorectal, or ovarian cancer. Venous thromboembolism risk was stratified using the COMPASS-CAT and Khorana scores. The primary outcome was objectively verified in-hospital venous thromboembolism. Discriminative performance was evaluated using receiver operating characteristic curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 482 patients, 53 (11.0%) developed in-hospital venous thromboembolism. The COMPASS-CAT model (score \u22657) demonstrated higher specificity (98.13% vs. 81.77%) and positive predictive value (82.22% vs. 35.00%) compared with the Khorana score (score \u22652). The COMPASS-CAT model exhibited significantly better overall discrimination, with an area under the curve of 0.913 versus 0.695 for the Khorana score (p\u2009&lt;\u20090.001). Univariate logistic regression revealed that a COMPASS-CAT score \u22657 was strongly associated with elevated venous thromboembolism risk (odds ratio = 20.66, 95% confidence interval: 9.96\u201342.83). A Khorana score \u22652 was also associated with an increased risk, but the magnitude was weaker (odds ratio = 3.26).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The COMPASS-CAT model exhibited a promising discriminative trend over the Khorana score for identifying the risk of in-hospital venous thromboembolism. Its notably higher specificity and positive predictive value suggest that it may serve as a helpful supplementary tool for targeted thromboprophylaxis in the inpatient oncology setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/03000605261471674","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:08:31Z","timestamp":1786630111000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["The COMPASS-CAT risk assessment model for predicting in-hospital venous thromboembolism in patients with breast, lung, colorectal, and ovarian cancer: A retrospective cohort study"],"prefix":"10.1177","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8366-3650","authenticated-orcid":false,"given":"Hualin","family":"Wei","sequence":"first","affiliation":[{"name":"Hebei General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2284-9518","authenticated-orcid":false,"given":"Wei","family":"Han","sequence":"additional","affiliation":[{"name":"Hebei General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4487-5868","authenticated-orcid":false,"given":"Xianbo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hebei General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8096-4867","authenticated-orcid":false,"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[{"name":"Hebei General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01461"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116327"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.209114"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0414"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-023-02860-4"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00010"},{"key":"e_1_3_3_8_2","first-page":"147","article-title":"Incidence of venous thromboembolism in ambulatory cancer patients receiving chemotherapy","volume":"126","author":"Shah MA","year":"2010","unstructured":"Shah MA, Cella D, Panneerselvam A, et al. Incidence of venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Thromb Res 2010; 126: 147\u2013150.","journal-title":"Thromb Res"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2013-0226"},{"key":"e_1_3_3_10_2","first-page":"132","article-title":"Predicting risk of venous thromboembolism in hospitalized cancer patients: utility of a risk assessment model","volume":"158","author":"Patell R","year":"2017","unstructured":"Patell R, Rybicki L, McCrae KR, et al. Predicting risk of venous thromboembolism in hospitalized cancer patients: utility of a risk assessment model. Thromb Res 2017; 158: 132\u2013137.","journal-title":"Thromb Res"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.669288"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-270116"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30063-2"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-012-0784-y"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0482"},{"key":"e_1_3_3_16_2","first-page":"760","article-title":"Central venous catheter thrombosis in cancer patients: the VITALI study","volume":"135","author":"Verso M","year":"2015","unstructured":"Verso M, Galli M, Agnelli G. Central venous catheter thrombosis in cancer patients: the VITALI study. Thromb Res 2015; 135: 760\u2013765.","journal-title":"Thromb Res"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007878"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010761"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00160-7"},{"key":"e_1_3_3_20_2","first-page":"12515667","article-title":"Establishment of a bleeding risk model for low-molecular-weight heparin anticoagulation in cancer patients","volume":"16","author":"Yan Y","year":"2025","unstructured":"Yan Y, et al. Establishment of a bleeding risk model for low-molecular-weight heparin anticoagulation in cancer patients. Front Pharmacol 2025; 16: 12515667.","journal-title":"Front Pharmacol"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.14.1471"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03195-0"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2016.02.030"},{"key":"e_1_3_3_24_2","first-page":"835","article-title":"Management of venous thromboembolism in cancer patients: guidance from the British committee for standards in haematology","volume":"196","author":"Noble S","year":"2022","unstructured":"Noble S, Alikhan R, Robbins A, et al. Management of venous thromboembolism in cancer patients: guidance from the British committee for standards in haematology. Br J Haematol 2022; 196: 835\u2013843.","journal-title":"Br J Haematol"}],"container-title":["Journal of International Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605261471674","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03000605261471674","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605261471674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T13:16:26Z","timestamp":1786799786000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03000605261471674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1177\/03000605261471674"],"URL":"https:\/\/doi.org\/10.1177\/03000605261471674","relation":{},"ISSN":["0300-0605","1473-2300"],"issn-type":[{"value":"0300-0605","type":"print"},{"value":"1473-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"article-number":"03000605261471674"}}